







































Scleral fixation of a single-piece foldable
acrylic IOL through a 1.80 mm
corneal incision
Daniele Veritti, MD, Lisa Grego, MD, Francesco Samassa, MD, Valentina Sarao, MD, Paolo Lanzetta, MD
A new scleral fixation technique of a single-piece acrylic fold-
able intraocular lens (IOL) (enVista MX60, Bausch & Lomb, Inc.)
through a 1.80 mm corneal incision, using the IOL eyelets as
anchoring point, is described. It was a retrospective review of
26 cases. The preoperative mean corrected distance visual
acuity was 0.51 ± 0.21 logarithm of the minimum angle of
resolution (logMAR). It improved significantly to 0.25 ± 0.27
logMAR (P < .01), 0.18 ± 0.16 logMAR (P < .01), and 0.17 ±
0.16 logMAR (P < .01) (at 1 month, 3 months, and 6 months
postoperatively, respectively, repeated measures analysis of
variance, P < .0001). No astigmatism increase of more than
0.75 diopters was recorded at any time point. In all 26 patients,
the IOL was well centered and stable for the entire monitoring
period. No complications were observed during follow-up.
Scleral fixation of the foldable IOL through a 1.80 mm corneal
incision provided excellent IOL stability during the 6-month
follow-up of this study and might be an effective and safe
surgical technique.
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Scleral fixation is one of the most widely used surgicaltechniques for implanting an intraocular lens (IOL) inthe posterior chamber (PC) when capsular support is
weak or missing.1–4 Scleral fixation offers several advan-
tages compared with other techniques used in the absence
of capsular support because scleral-sutured PC IOLs do not
make contact with the corneal endothelium, iris, or tra-
becular meshwork, thus reducing the risk of pigment
dispersion, iris tissue damage, endothelial dystrophy, and
glaucoma. Furthermore, scleral-sutured IOLs provide
a barrier function between the anterior chamber and the
vitreous cavity.5–8 The classic scleral fixation technique
requires a large sclerocorneal incision of about 6.50 mm to
insert the IOL into the PC. Large incisions are typically
needed because conventional scleral-fixated IOLs are made
of poly(methyl methacrylate), a rigid material that cannot
be folded and have a large diameter. Large incisions are
associated with many complications, such as intraoperative
and postoperative hypotonia, postoperative astigmatism,
choroidal detachment, and issues related to wound closure
(eg, wound leakage with potential loss of the anterior
chamber, suture-induced astigmatism, and higher risk of
infections).9–11 To avoid the complications associated with
large scleral incisions, new surgical techniques for scleral
fixation using foldable IOLs were developed.12–19 Foldable
IOLs eliminate the need to extend the incision for im-
plantation, thus reducing the final corneal astigmatism and
allowing a better visual rehabilitation.6 The single-piece
hydrophobic acrylic foldable IOL (enVistaMX60, Bausch &
Lomb, Inc.) was introduced in 2012. This IOL is charac-
terized by eyelets located at the junction of the aspheric
optic and C-loop haptics that can be used for suture
placement (Figure 1). It received the Conformité Euro-
péenne marking in August 2010 and was subsequently
approved by the U.S. Food and Drug Administration in
May 2012. In standard practice, the MX60 IOL is implanted
in the capsular bag after phacoemulsification through
a 1.80 mm corneal incision. With the standard in-the-bag
placement technique, this IOL demonstrated a well-
established safety profile.20 Among many advantages, the
MX60 IOL showed stable refractive outcomes and a low
incidence of Nd:YAG laser capsulotomies 12 months
postoperatively.21,22 Although this IOL has been designed to
be implanted into the capsular bag, its features and physical
characteristics might provide good surgical stability and
handling during scleral fixation, including a comfortable
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intraoperative suture management outcomes of a new sur-
gical technique that allows scleral fixation of a single-piece
acrylic foldable IOL through a 1.80 mm corneal incision is
presented.
SURGICAL TECHNIQUE
All surgeries were performed by the same surgeon (P.L.).
After administration of peribulbar anesthesia, a 1.80 mm
corneal incision was performed at 12 o’clock. Conjunctival
peritomy was performed at 3 o’clock and 9 o’clock, and
then 2 triangular, partial-thickness scleral flaps were cre-
ated near the limbus. A double-armed 10-0 polypropylene
suture (30 cm ½ circle side cutting AUM-5, straight side
cutting SC5 polypropylene blue monofilament, Alcon) was
passed from the 9 o’clock scleral flap to the 3 o’clock scleral
flap, 1.50 mm posterior to the limbus with an out-in
technique using a 27-gauge needle (0.4 × 20.0 mm, Ni-
pro Co). The suture was then drawn out of the corneal
tunnel using forceps (eg, 25- or 27-gauge Eckardt forceps)
(Figure 2). The suture loop thus formed was inserted into
the injector cartridge (Viscoject Bio 1.8, Carl Zeiss Meditec
AG). The suture was cut, and the 2 suture ends were tied to
the IOL eyelets. The IOL was then injected into the eye
through the 1.80 mm corneal incision using a modified
cartridge while tension was applied to the other ends of
the sutures. The IOL was spread and centered, and the 10-0
polypropylene suture ends were fixed to the sclera. The
scleral flaps were repositioned, and the conjunctiva was
sutured (Video 1, Supplemental Digital Content, available
at http://links.lww.com/JRS/A34).
Baseline and follow-up data were analyzed using re-
peated measures analysis of variance, with Greenhouse-
Geisser correction and a significance level of 5%. Serial
comparisons were performed using the Dunnett multiple
comparisons test.
Results
A total of 26 eyes (26 patients) were enrolled in the study
from the Department of Medicine-Ophthalmology at the
University of Udine and from the Istituto Europeo di
Microchirurgia Oculare from June 2014 to June 2017. This
study was conducted in compliance with the tenets of the
Declaration of Helsinki and approved by the institutional
review board. Written informed consent was taken from all
Figure 1. Schematic representation of the MX60 intraocular lens. It
is characterized by the eyelets located at the junction of the aspheric
optic and C-loop haptics.
Figure 2. Graphical representation of the surgical procedure for
scleral fixation of the MX60 IOL through a 1.80 mm corneal in-
cision. A: A polypropylene suture is passed from 9 o’clock scleral
flap to 3 o’clock scleral flap. B: The suture is drawn out from the
1.80 mm corneal tunnel using forceps. C: The IOL is loaded onto
the cartridge and then implanted in the posterior chamber. D: The
IOL is centered using the polypropylene suture ends (IOL = in-
traocular lens).
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patients. Included were patients who underwent scleral
fixation of aMX60 IOL through a 1.80 mm incision because
of post–cataract surgery aphakia with an inadequate cap-
sular support and a subluxated and luxated crystalline lens
because of ocular trauma.
Patients were evaluated at baseline, days 1 and 7, andmonths
1, 3, and 6 postoperatively. Preoperative conditions, surgical
times, duration of follow-up, and the results of the surgery in
terms of corrected distance visual acuity (CDVA), post-
operative astigmatism, centering and stability of the IOL, and
intraoperative and postoperative complications were recorded.
All 26 patients completed the 6-month follow-up
schedule. Clinical characteristics, preoperative diagnoses,
and comorbidities are summarized in Table 1.
Ten patients required additional posterior and/or ante-
rior segment procedures at the time of the scleral IOL
fixation procedure, such as phacoemulsification of the
luxated lens and anterior or posterior vitrectomy. The mean
surgery time for all 26 patients was 58 ± 18 minutes (range
35 to 80 minutes), whereas for patients requiring only the
scleral fixation procedure, it was 42 ± 10 minutes (range 35
to 60 minutes). The mean CDVA improved significantly
postoperatively (P < .0001). CDVA changes are summa-
rized in Table 2. In all 26 patients, the IOL was well centered
and stable for the entire follow-up period (Figure 3).
No astigmatism increase of more than 0.75 diopters was
recorded at any time point. Cystoid macular edema,
choroidal detachment, vitreous hemorrhage, or other
complications were not observed during the follow-up.
DISCUSSION
In the absence of adequate capsular support, different
techniques can be used for IOL implantation, such as im-
plantation in the anterior chamber, iris fixation, or scleral
fixation. Implantation of the anterior chamber IOL is
a simple surgical technique, but it is associated with an
increased risk of corneal decompensation, glaucoma,
cystoid macular edema, and uveitis–glaucoma–hyphema
syndrome.2–4,23 The iris-sutured lenses increase the risk of iris
atrophy, uveitis, and cystoid macular edema.3,6 Scleral fixation
is one of the most used techniques when an adequate capsular
support is not present, because of a lower incidence of
complications and greater stability of the IOL when compared
with other techniques.24 Although it provides a good safety
profile, complications such as erosion of sutures, cystoid
macular edema, vitreous hemorrhage, dislocation of the IOL,
retinal detachment, and side effects related to large incisions
have been observed.25
To reduce the complication rate, several variants of the
classical scleral fixation technique have been developed,
mostly directed at reducing the incision size.3,22,26
In 2015, Yang et al. described for the first time the results
of surgical scleral fixation of theMX60 IOL, using the eyelets
located at the optic–haptic junction for suture placement.
The IOL was threaded with sutures, folded in half, and
inserted with forceps into the anterior chamber through
a 3.50 mm corneal incision. Their technique allowed for
reporting an easy centration of the IOL and a stable IOL
position. A transient postoperative hypotony was noted in
7% of cases.22
Recently, Morkin and Patterson proposed a new IOL
insertion method, using injector systems, allowing
a 2.75 mm corneal incision using an hydrophilic acrylic IOL
(Akreos A065, Bausch & Lomb, Inc.) prethreaded with
sutures and mounted in a cartridge (Monarch III system,
Alcon). The authors reported that the benefits of inserting
the IOL with an injector system and through a smaller
wound include less surgically induced astigmatism and
faster rehabilitation time, with a presumed low incidence of
hypotony and other complications.27
Here, we describe a modified technique that uses the
MX60 IOL and an injector system with many advantages.
This foldable IOL allows implantation through a 1.80 mm
corneal incision and shows a greater stability because of 4
support points: 2 sutures fixed to the eyelets and 2 haptics
placed in the ciliary sulcus.22 This is also supported by our
results in that no IOL decentration or dislocation was ob-
served. In addition, no intraoperative or postoperative
complications were reported. To our knowledge, this is the
first report to describe a scleral fixation technique using
a corneal incision inferior to 2.0 mm. This technique does
not represent a complex procedure and can be easily and
quickly learnt by ophthalmic surgeons.
We used a polypropylene suture, which is the most
commonly used suture material for scleral-fixated IOL
techniques. However, concerns regarding suture breaking
and degradation have been raised in the past. In a recent
article, Kokame et al. showed that scleral fixation with a 10-0
polypropylene suture provides an excellent long-term fixa-
tion of PC IOLs. IOLs remained well stabilized and posi-
tioned at the last follow-up in 116 (98.3%) of 118 eyes with
a mean follow-up of 6 years. The maximum stable follow-up
Table 1. Baseline characteristics.
Characteristic n = 26
Age (y, mean ± SD) (range) 69.3 ± 13.1 (50, 89)
Female sex (n, %) 10 (38)
CDVA, logMAR (mean ± SD) (range) 0.51 ± 0.21 (0.8, 0.1)
Comorbidities (n, %) 8 (31)
Dry AMD 3 (12)
Glaucoma 2 (8)
Proliferative DR (laser-treated) 1 (4)




Preoperative IOP (mm Hg, mean ± SD)
(range)
15.8 ± 2.3 (10, 21)
SE (D, mean ± SD) (range) +9.2 ± 5.3 (1.5, +22)




Traumatic lens subluxation/luxation 2 (8)
PCR (at the time of surgery) 6 (23)
AMD = age-related macular degeneration; CDVA = corrected distance
visual acuity; DR = diabetic retinopathy; logMAR = logarithm of the
minimum angle of resolution; PCR = posterior capsule rupture;
SE = spherical equivalent
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with 2 intact fixation sutures was 24.75 years.28 The Gore-
Tex suture could become a valuable alternative to the
polypropylene suture. However, at the moment, the largest
case series describing the use of the Gore-Tex suture for
scleral fixation has a relatively short follow-up (325 days).
Moreover, the authors themselves underline that the use of
the Gore-Tex suture in the eye is currently off-label.29
This study has some limitations, including a small sample
size and a relatively short postoperative follow-up period.
Important complications, such as suture erosion, IOL
dislocation, and tilting, might be observed in a longer
follow-up period.
Scleral fixation of the MX60 IOL through a 1.80 mm
corneal incision might be an effective and safe surgical
technique that provides excellent stability of the IOL,
although the follow-up of this study is relatively short
(6 months). Compared with other scleral fixation tech-
niques, it allows IOL implantation through the smallest
corneal incision reported in the literature, to our
knowledge. Studies with a larger sample and a longer
follow-up period are needed to determine the safety and
long-term efficacy of the surgical technique described in
this article.
WHAT WAS KNOWN
 Scleral fixation is a widely used technique for intraocular lens
(IOL) implantation. The use of foldable IOLs eliminates the
need for large incisions, thus reducing the incidence of
postoperative astigmatism and facilitating a faster healing.
WHAT THIS PAPER ADDS
 To our knowledge, this is the first report to describe a scleral
fixation technique using a corneal incision inferior to 2.0 mm.
 Because many complications of scleral fixation are related to
a large incision, this technique might provide better
outcomes.
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